Abstract
The interaction of integrins with their ligands is an essential step in regulating many cellular functions (1). The β2 integrins, which are exclusively expressed on leukocytes, are of critical importance for leukocyte functions (2–5). The discovery of an inherited defect in leukocyte adhesion (called leukocyte adhesion deficiency, LAD), caused by the lack of expression of β2 integrins on the cell surface, underscored the important biological role of these receptors in the inflammatory and immune responses (6).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hynes, R. O. (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69, 11–26.
Arnaout, M. A. (1990) Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75, 1037–1050.
Springer, T. A. (1990) Adhesion receptors of the immune system. Nature 345,425.
Gahmberg, C. G, Nortamo, P., Li, R., and Valmu, L. (1992) Leukocyte cell adhesion proteins: from molecular dissection to clinical applications. Ann. Med. 24, 229–335.
Gahmberg, C. G, Tolvanen, M., and Kotovuori, P. (1997) Leukocyte adhesion-structure and function of human leukocyte b2-integrins and their cellular ligands. Eur. J. Biochem. 245, 215–232.
Arnaout, M. A. (1990) Leukocyte adhesion molecule deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. [review]. Immunol. Rev. 114, 145–180.
Springer, T. A. (1997) Folding of the N-terminal, ligand-binding region of integrin a-subunits into α β-propeller domain. Proc. Natl. Acad. Sci. USA 94, 65–72.
Lee, J.-O., Rieu P., Arnaout M. A., and Liddington, R. (1995) Crystal Structure of the A-domain from the α-subunit of β2 integrin complement receptor type 3 (CR3, CD11b/CD18). Cell 80, 631–638.
Goodman, T. G. and Bajt, M. L. (1996) Identifying the putative metal ion-dependent adhesion site in the β2 (CD18) subunit required for αLβ2 and αMβ2 ligand interactions. J. Biol. Chem. 271, 23,729–23,736.
Michishita, M., Videm V., and Arnaout, M. A. (1993) A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell 72, 857–867.
Ueda, T., Rieu P., Brayer J., and Arnaout, M. A. (1994) Identification of the complement iC3b binding site in the β2 integrin CR3 (CD11b/CD18). Proc. Natl. Acad. Sci. USA 91, 10,680–10,684.
Randi, A. M. and Hogg, N. (1994) I Domain of β2 integrin lymphocyte-associated-antigen 1 contains a binding site for ligand intercellular adhesion molecule-1. J. Biol. Chem. 269, 12,395–12,398.
Rieu, P., Ueda T., Haruta I., Sharma C. P., and Arnaou, M. A. (1994) The A-domain of β2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF. J. Cell Biol. 127, 2081–2091.
Zhou, L., Lee D. H., Plescia J., Lau C. Y., and Altieri, D. C. (1994) Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain. J. Biol. Chem. 269, 17,075–17,079.
Muchowski, P. J., Zhang L., Chang E. R., Soule, H. R., Plow, E. F., and Moyle, M. (1994) Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18. J. Biol. Chem. 269, 26,419–26,423.
Qu, A. and Leahy, D. J. (1995) Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, αLβ2) integrin. Proc. Natl. Acad. Sci. USA 92, 10,277–10,281.
Arnaout, M. A., Spits, H., Terhorst, C, Pitt, J., and Todd, R. F., III (1984) Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency: effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J. Clin. Invest. 74, 1291–1300.
Todd, R. F., III, Arnaout, M. A., Rosin, R. E., Crowley, C. A., Peters, W. A., Curnutte, J. T, and Babior, B. M. (1984) Subcellular localization of the subunit of Mo1 (Mo1 alpha; formerly gp110), a surface glycoprotein associated with neutrophil adhesion. J. Clin. Invest. 74, 1280–1290.
Miller, L. J., Bainton, D. F., Borregaard, N., and Springer, T. A. (1987) Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J. Clin. Invest. 80, 535–544.
Detmers, P. A., Wright, S. D., Olsen, E., Kimball, B., and Cohn, Z. A. (1987) Aggregation of complement receptors on human neutrophils in the absence of ligand. J. Cell. Biol. 105, 1137–1145.
Kupfer, A. and Singer, S. J. (1988) Molecular dynamics in the membranes of helper T cells. Proc. Natl. Acad. Sci. USA 85, 8216.
Rieu, P. and Arnaout, M. A. (1996) The structural basis and regulation of β2 integrin interactions, in Adhesion Molecules and the Lung (Ward, P., Fantone, J. C, eds.), Marcel Dekker, New York, NY, pp. 1–42.
Dustin, M. L. and Springer, T. M. (1989) T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341, 619–624.
Altieri, D. C. (1991) Occupancy of CD11b/CD18 (Mac-1) divalent ion binding site(s) induces leukocyte adhesion. J. Immunol. 147, 1891–1896.
Dransfield, I., Cabanas, C, Craig, A., and Hogg, N. (1992) Divalent cation regulation of the function of the leukocyte integrin LFA-1. J. Cell Biol. 116, 219–226.
Kohler, G. and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495.
Harlow, E. and Lane, D. (1988) Antibodies. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 285–316.
Arnaout, M. A., Pierce, M., Dana, N., and Clayton, L. K. (1987) Complement receptor type 3 (CR3): structure and function, in Methods In Enzymology, vol. 150 (DiSabato, G., Langone, J. J., and VanVanaskis, H., eds.), Acad. Press, FL, pp. 602–615.
Arnaout, M. A. (1993) Dynamics and regulation of leukocyte-endothelial interactions. Curr. Opin. Hematol. 1, 113–122.
Languino, L. R., Plescia, J., Duperray, A., Brain, A. A., Plow, E. F., Geltosky, J. E., and Altieri, D. C. (1993) Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell 73, 1423–1434.
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., and Springer, T. A. (1986) A natural adherence molecule (ICAM-1): induction by IL1 and interferon-gamma, tissue distribution, biochemistry and function. J. Immunol. 137,245–254.
Rothlein, R., Czajkowski, M., O’Neil, M. M., Marlin, S. D., Mainolfi, E., and Merluzzi, V. J. (1988) Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. J. Immunol. 141, 1665–1669.
de Fougerolles, A. D., Stacker, S. A., Schwarting, R., and Springer, T. A. (1991) Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med. 174, 253–267.
Nortamo, P., Salcedo, R., Timonen, T., Patarroyo, M., and Gahmberg, C. G (1991) A monoclonal antibody to the human leukocyte adhesion molecule intercellular adhesion molecule-2. J. Immunol. 146, 2530–2535.
Rothlein, R., Mainolfi, E., Czajkowski, M., and Marlin, S. D., (1991) A form of circulating ICAM-1 in human serum. J. Immunol. 147, 3788–3793.
Staunton, D. E., Ockenhouse, C. F., and Springer, T. A. (1992) Soluble intercellular adhesion molecule 1-immunoglobulin G1 immunoadhesin mediates phagocytosis of malaria-infected erythrocytes. J. Exp. Med. 176, 1471–1476.
Welder, C. A., Lee, D. H. S., and Takei, F. (1993) Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1. J. Immunol. 150, 2203–2210.
Reilly, P. L., Woska, J. R., Jeanfavre, D. D., McNally, E., Rothlein, R., and Bormann, B.-J. (1995) The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. J. Immunol. 155, 529–532.
Miller, L. J., Knorr, R., Ferrone, M., Houdei, R., Carron, C. P., and Dustin, M. L. (1995) Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function-associated antigen-1. J. Exp. Med. 182,1231–1241.
Xie, J., Li, R., Kotovuori, P., Vermot-Desroches, C, Wijdenes, J., Arnaout, M. A., Nortamo, P., and Gahmberg, C. G. (1995) Intercellular adhesion molecule-2 (CD102) binds to the leukocyte integrin CD11b/CD18 through the A domain. J. Immunol. 155, 3619–3628.
Arnaout, M. A., Todd, R. F., III, Dana, N., Melamed, J., Schlossman, S. F., and Colten, H. R. (1983) Inhibition of phagocytosis of complement C3-or immunoglobulin G-coated particles and of iC3b binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mo1). J. Clin. Invest. 72,171–179.
Rothlein, R. and Springer T. A. (1985) Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages. J. Immunol. 135, 2668–2672.
O’Rear, L. D. and Ross G D. (1994) Assays for membrane complement receptors, in Current Protocols in Immunology, vol supplement 10, Wiley, New York, NY, pp. 13.4.1–13.4.18.
Cai, T. Q. and Wright, S. D. (1995) Energetics of leukocyte integrin activation. J. Biol. Chem. 270, 14,358–14,365.
Cai, T. Q., Law, S. K., Zhao, H. R., and Wright, S. D. (1995) Reversible inactivation of purified leukocyte integrin CR3 (CD11b/CD18, alpha m beta 2) by removal of divalent cations from a cryptic site. Cell Adhes. Commun. 3, 399–406.
Altieri, D. C, Plescia, J., and Plow, E. (1993) The structural motif glycine 190-valine 202 of the fibrinogen g chain interacts with CD11b/CD18 integrin (αMβ2, Mac-1) and promote leukocyte adhesion. J. Biol. Chem. 268, 1847–1853.
Li, R., Xie, J., Kantor, C, Koistinen, V., Altieri, D. C, Nortamo, P., and Gahmberg, C. G. (1995) A peptide derived from the intercellular adhesion molecule-2 regulates the avidity of the leukocyte integrins CD11b/CD18 and CD11c/CD18. J. Cell Biol. 129, 1143–1153.
Li, R, Nortamo, P., Valmu, L., Tolvanen, M., Huuskonen, J., Kantor, C, and Gahmberg, C. G (1993) A peptide from ICAM-2 binds to the leukocyte integrin CD11a/CD18 and inhibits endothelial cell adhesion. J. Biol. Chem. 268, 17,513–17,518.
Diamond, M. S., Staunton, D. E., DeFougerolles, A. R., Stacker, S. A., Garcia-Aguilar, J., Hibbs, M. L., and Springer, T. A (1990) ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 111, 3129–3139.
Van Strijp, J. A. G, Russell, D. G, Tuomanen, E., Brown, E. J., and Wright, S. D. (1993) Ligand specificity of purified complement receptor type three (CD11b/CD18, αMβ2, Mac-1). J. Immunol. 151, 3324–3336.
Miller, J. M., Schwarting, R., and Springer, T. A. (1986) Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation. J. Immunol. 137, 2891–2900.
Lee, J.-O., Anne-Bankston, L., Arnaout, M. A., and Liddington, R. C. (1995) Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure 3, 1333–1340.
Winzor, D. J. Sawyer, W. H. (1995) Quantitative Characterization of Ligand Binding. Wiley-Liss, Inc. 1–11.
Li, R., Nortamo, P., Kantor, C., Kovanen, P., Timonen, T., and Gahmberg, C. G. (1993) A leukocyte integrin binding peptide from intercellular adhesion molecule-2 stimulates T cell adhesion and natural killer cell activity. J. Biol. Chem. 268, 21,474–21,477.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc.
About this protocol
Cite this protocol
Li, R., Arnaout, M.A. (1999). Functional Analysis of the β2 Integrins. In: Howlett, A. (eds) Integrin Protocols. Methods in Molecular Biology, vol 129. Humana Press. https://doi.org/10.1385/1-59259-249-X:105
Download citation
DOI: https://doi.org/10.1385/1-59259-249-X:105
Publisher Name: Humana Press
Print ISBN: 978-0-89603-569-0
Online ISBN: 978-1-59259-249-4
eBook Packages: Springer Protocols